Elizabeth Holmes trial witness: Theranos, tests showing male protein in women’s blood, voided at least 50,000 test results

Elizabeth Holmes trial witness: Theranos, tests showing male protein in women’s blood, voided at least 50,000 test results

3 years ago
Anonymous $np3LcwuhSi

https://www.siliconvalley.com/2021/11/09/elizabeth-holmes-trial-witness-theranos-tests-showing-male-protein-in-womens-blood-voided-at-least-50000-test-results/

Theranos’ blood-testing machines were showing women with a male protein in their blood, and company founder Elizabeth Holmes gave an “implausible” excuse for the apparent errors, a former lab director testified Tuesday in Holmes’ criminal trial before revealing that he voided at least 50,000 test results from the startup’s “malperforming” machines.

Former Theranos lab director Dr. Kingshuk Das was testifying for the prosecution in U.S. District Court in San Jose about a federal regulatory report that found deficiencies in Theranos’ testing that the regulator alleged put patients in “immediate jeopardy” of serious harm or death. Das testified that he told Holmes about women’s blood showing significant levels of prostate-specific antigen — a protein typically found only in trace elements in women — because those results provided an “easily digestible” example of Theranos’ machines “propensity” for errors. Holmes responded by providing Das with “an article or two” describing a rare phenomenon of breast cancer tumors in women producing the protein.

Elizabeth Holmes trial witness: Theranos, tests showing male protein in women’s blood, voided at least 50,000 test results

Nov 10, 2021, 5:13am UTC
https://www.siliconvalley.com/2021/11/09/elizabeth-holmes-trial-witness-theranos-tests-showing-male-protein-in-womens-blood-voided-at-least-50000-test-results/ > Theranos’ blood-testing machines were showing women with a male protein in their blood, and company founder Elizabeth Holmes gave an “implausible” excuse for the apparent errors, a former lab director testified Tuesday in Holmes’ criminal trial before revealing that he voided at least 50,000 test results from the startup’s “malperforming” machines. > Former Theranos lab director Dr. Kingshuk Das was testifying for the prosecution in U.S. District Court in San Jose about a federal regulatory report that found deficiencies in Theranos’ testing that the regulator alleged put patients in “immediate jeopardy” of serious harm or death. Das testified that he told Holmes about women’s blood showing significant levels of prostate-specific antigen — a protein typically found only in trace elements in women — because those results provided an “easily digestible” example of Theranos’ machines “propensity” for errors. Holmes responded by providing Das with “an article or two” describing a rare phenomenon of breast cancer tumors in women producing the protein.